WHO adds Roche's arthritis drug tocilizumab to COVID-19 medicines list

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann

GENEVA, Feb 11 (Reuters) - The World Health Organization said on Friday it had added its first monoclonal antibody tocilizumab to its so-called pre-qualification list, an official list of medicines used as a benchmark for procurement by developing countries.

The WHO recommended the drug, manufactured by Roche and typically used to treat arthritis, only for patients diagnosed with severe or critical COVID-19.

Reporting by Emma Farge

Our Standards: The Thomson Reuters Trust Principles.